TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR

Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures whe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DRANSFIELD, Paul John, HOUZE, Jonathan, MA, Zhihua, DEBENEDETTO, Mikkel V, LAI, Su-Jen, HARVEY, James S, PATTAROPONG, Vatee, CHEN, Yinhong, KHAKOO, Aarif Yusuf, MOEBIUS, David C, CHENG, Alan C, KREIMAN, Charles, SHARMA, Ankit, SWAMINATH, Gayathri
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DRANSFIELD, Paul John
HOUZE, Jonathan
MA, Zhihua
DEBENEDETTO, Mikkel V
LAI, Su-Jen
HARVEY, James S
PATTAROPONG, Vatee
CHEN, Yinhong
KHAKOO, Aarif Yusuf
MOEBIUS, David C
CHENG, Alan C
KREIMAN, Charles
SHARMA, Ankit
SWAMINATH, Gayathri
description Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2019300507A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2019300507A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2019300507A13</originalsourceid><addsrcrecordid>eNrjZLAKCfJ0jPL3cVUIiAzydIn0UXD29w3wD_VzCVZwBCJ3fz_P4JBgBX83hRAPVwXHAC-FIFdn14AQ_yAeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGhpbGBgamDuaGhMnCoAbpoqCw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR</title><source>esp@cenet</source><creator>DRANSFIELD, Paul John ; HOUZE, Jonathan ; MA, Zhihua ; DEBENEDETTO, Mikkel V ; LAI, Su-Jen ; HARVEY, James S ; PATTAROPONG, Vatee ; CHEN, Yinhong ; KHAKOO, Aarif Yusuf ; MOEBIUS, David C ; CHENG, Alan C ; KREIMAN, Charles ; SHARMA, Ankit ; SWAMINATH, Gayathri</creator><creatorcontrib>DRANSFIELD, Paul John ; HOUZE, Jonathan ; MA, Zhihua ; DEBENEDETTO, Mikkel V ; LAI, Su-Jen ; HARVEY, James S ; PATTAROPONG, Vatee ; CHEN, Yinhong ; KHAKOO, Aarif Yusuf ; MOEBIUS, David C ; CHENG, Alan C ; KREIMAN, Charles ; SHARMA, Ankit ; SWAMINATH, Gayathri</creatorcontrib><description>Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191003&amp;DB=EPODOC&amp;CC=US&amp;NR=2019300507A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191003&amp;DB=EPODOC&amp;CC=US&amp;NR=2019300507A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DRANSFIELD, Paul John</creatorcontrib><creatorcontrib>HOUZE, Jonathan</creatorcontrib><creatorcontrib>MA, Zhihua</creatorcontrib><creatorcontrib>DEBENEDETTO, Mikkel V</creatorcontrib><creatorcontrib>LAI, Su-Jen</creatorcontrib><creatorcontrib>HARVEY, James S</creatorcontrib><creatorcontrib>PATTAROPONG, Vatee</creatorcontrib><creatorcontrib>CHEN, Yinhong</creatorcontrib><creatorcontrib>KHAKOO, Aarif Yusuf</creatorcontrib><creatorcontrib>MOEBIUS, David C</creatorcontrib><creatorcontrib>CHENG, Alan C</creatorcontrib><creatorcontrib>KREIMAN, Charles</creatorcontrib><creatorcontrib>SHARMA, Ankit</creatorcontrib><creatorcontrib>SWAMINATH, Gayathri</creatorcontrib><title>TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR</title><description>Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAKCfJ0jPL3cVUIiAzydIn0UXD29w3wD_VzCVZwBCJ3fz_P4JBgBX83hRAPVwXHAC-FIFdn14AQ_yAeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGhpbGBgamDuaGhMnCoAbpoqCw</recordid><startdate>20191003</startdate><enddate>20191003</enddate><creator>DRANSFIELD, Paul John</creator><creator>HOUZE, Jonathan</creator><creator>MA, Zhihua</creator><creator>DEBENEDETTO, Mikkel V</creator><creator>LAI, Su-Jen</creator><creator>HARVEY, James S</creator><creator>PATTAROPONG, Vatee</creator><creator>CHEN, Yinhong</creator><creator>KHAKOO, Aarif Yusuf</creator><creator>MOEBIUS, David C</creator><creator>CHENG, Alan C</creator><creator>KREIMAN, Charles</creator><creator>SHARMA, Ankit</creator><creator>SWAMINATH, Gayathri</creator><scope>EVB</scope></search><sort><creationdate>20191003</creationdate><title>TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR</title><author>DRANSFIELD, Paul John ; HOUZE, Jonathan ; MA, Zhihua ; DEBENEDETTO, Mikkel V ; LAI, Su-Jen ; HARVEY, James S ; PATTAROPONG, Vatee ; CHEN, Yinhong ; KHAKOO, Aarif Yusuf ; MOEBIUS, David C ; CHENG, Alan C ; KREIMAN, Charles ; SHARMA, Ankit ; SWAMINATH, Gayathri</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2019300507A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DRANSFIELD, Paul John</creatorcontrib><creatorcontrib>HOUZE, Jonathan</creatorcontrib><creatorcontrib>MA, Zhihua</creatorcontrib><creatorcontrib>DEBENEDETTO, Mikkel V</creatorcontrib><creatorcontrib>LAI, Su-Jen</creatorcontrib><creatorcontrib>HARVEY, James S</creatorcontrib><creatorcontrib>PATTAROPONG, Vatee</creatorcontrib><creatorcontrib>CHEN, Yinhong</creatorcontrib><creatorcontrib>KHAKOO, Aarif Yusuf</creatorcontrib><creatorcontrib>MOEBIUS, David C</creatorcontrib><creatorcontrib>CHENG, Alan C</creatorcontrib><creatorcontrib>KREIMAN, Charles</creatorcontrib><creatorcontrib>SHARMA, Ankit</creatorcontrib><creatorcontrib>SWAMINATH, Gayathri</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DRANSFIELD, Paul John</au><au>HOUZE, Jonathan</au><au>MA, Zhihua</au><au>DEBENEDETTO, Mikkel V</au><au>LAI, Su-Jen</au><au>HARVEY, James S</au><au>PATTAROPONG, Vatee</au><au>CHEN, Yinhong</au><au>KHAKOO, Aarif Yusuf</au><au>MOEBIUS, David C</au><au>CHENG, Alan C</au><au>KREIMAN, Charles</au><au>SHARMA, Ankit</au><au>SWAMINATH, Gayathri</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR</title><date>2019-10-03</date><risdate>2019</risdate><abstract>Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2019300507A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T21%3A15%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DRANSFIELD,%20Paul%20John&rft.date=2019-10-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2019300507A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true